Diet in Patients with Myocardial Infarction and Coexisting Type 2 Diabetes Mellitus.
coronary artery diseases
diabetes mellitus
dietary awareness
dietary deviations
dietary prevention
Journal
International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455
Informations de publication
Date de publication:
07 04 2023
07 04 2023
Historique:
received:
31
01
2023
revised:
30
03
2023
accepted:
03
04
2023
medline:
1
5
2023
pubmed:
28
4
2023
entrez:
28
4
2023
Statut:
epublish
Résumé
Dietary modifications are recommended alongside pharmacotherapy in treating both diabetes mellitus (DM) and coronary heart disease (CHD) patients. The primary aim of our study was to assess the diet in patients with type 2 diabetes mellitus (T2DM) and myocardial infarction (MI) and to identify dietary differences between patients after the first and subsequent cardiovascular (CV) event. The secondary aim was to analyze the differences between men's and women's diets. The study population consisted of patients with DM/T2DM and MI. The research tool was the original author's questionnaire which was collected personally by a qualified dietician. The study included 67 patients with a mean age of 69 ± 8 years, hospitalized at the Silesian Centre for Heart Diseases in Zabrze in 2019. The study found that patients consumed less bread, whole-grain cereal products, fermented milk products, and vegetables than was recommended. A total of 32.8% of patients reported an intake of sweetened beverages, while 85.1% of participants consumed sweets despite being diagnosed with DM. Except for sweetened drinks, no differences in dietary behaviors were found in the patients after the first and second MI episode. Most of the included patients assessed their diet as appropriate. The dietary assessment of diabetes and myocardial infarction patients indicates that the diet does not comply with dietary recommendations, thus increasing the risk of a recurrent cardiac event despite a previous MI. No differences between the men's and the women's nutritional habits were observed.
Sections du résumé
BACKGROUND
Dietary modifications are recommended alongside pharmacotherapy in treating both diabetes mellitus (DM) and coronary heart disease (CHD) patients.
AIMS
The primary aim of our study was to assess the diet in patients with type 2 diabetes mellitus (T2DM) and myocardial infarction (MI) and to identify dietary differences between patients after the first and subsequent cardiovascular (CV) event. The secondary aim was to analyze the differences between men's and women's diets.
METHODS
The study population consisted of patients with DM/T2DM and MI. The research tool was the original author's questionnaire which was collected personally by a qualified dietician.
RESULTS
The study included 67 patients with a mean age of 69 ± 8 years, hospitalized at the Silesian Centre for Heart Diseases in Zabrze in 2019. The study found that patients consumed less bread, whole-grain cereal products, fermented milk products, and vegetables than was recommended. A total of 32.8% of patients reported an intake of sweetened beverages, while 85.1% of participants consumed sweets despite being diagnosed with DM. Except for sweetened drinks, no differences in dietary behaviors were found in the patients after the first and second MI episode. Most of the included patients assessed their diet as appropriate.
CONCLUSION
The dietary assessment of diabetes and myocardial infarction patients indicates that the diet does not comply with dietary recommendations, thus increasing the risk of a recurrent cardiac event despite a previous MI. No differences between the men's and the women's nutritional habits were observed.
Identifiants
pubmed: 37107724
pii: ijerph20085442
doi: 10.3390/ijerph20085442
pmc: PMC10138621
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Nutrients. 2022 Jun 27;14(13):
pubmed: 35807830
Circ Res. 2017 Sep 1;121(6):677-694
pubmed: 28860318
Lancet. 2022 May 14;399(10338):1876-1885
pubmed: 35525255
Int J Epidemiol. 2021 Mar 3;50(1):212-222
pubmed: 33245137
Lancet. 2020 Aug 22;396(10250):565-582
pubmed: 32828189
Int J Environ Res Public Health. 2019 Sep 29;16(19):
pubmed: 31569534
Lancet. 2007 Mar 31;369(9567):1090-8
pubmed: 17398308
Circ Res. 2019 Apr 12;124(8):1160-1162
pubmed: 30973809
Cardiovasc Diabetol. 2018 Jun 8;17(1):83
pubmed: 29884191
BMJ. 2020 Jan 8;368:l6669
pubmed: 31915124
Cochrane Database Syst Rev. 2020 May 19;5:CD011737
pubmed: 32428300
Heart. 2016 Jul 15;102(14):1142-9
pubmed: 27126397
Eur Heart J. 2021 Sep 7;42(34):3227-3337
pubmed: 34458905
Diabetes Care. 2020 Sep;43(9):2050-2059
pubmed: 32651263
Nutrients. 2019 Nov 19;11(11):
pubmed: 31752333
Circulation. 2019 May 28;139(22):2516-2527
pubmed: 30882239
Eur Heart J. 2020 Jan 7;41(2):255-323
pubmed: 31497854
BMC Cardiovasc Disord. 2020 Sep 24;20(1):425
pubmed: 32972356
Nutrients. 2019 Nov 01;11(11):
pubmed: 31683759
J Am Coll Cardiol. 2020 Nov 3;76(18):2089-2097
pubmed: 33121716
Sci Rep. 2019 Feb 28;9(1):3091
pubmed: 30816213
Lancet Diabetes Endocrinol. 2019 Sep;7(9):715-725
pubmed: 31301983
Nutrients. 2021 Nov 19;13(11):
pubmed: 34836405
Eur Heart J. 2020 Oct 21;41(40):3925-3932
pubmed: 32860032
N Engl J Med. 2019 Jan 3;380(1):11-22
pubmed: 30415628
Clin Nutr. 2021 Jan;40(1):255-276
pubmed: 32620446
Br J Gen Pract. 2018 Mar;68(668):151-152
pubmed: 29472228